Wishing you all the joys of the season! 
Middle East & Africa Myopia Treatment Market Forecast to 2030
Middle East & Africa Myopia Treatment Market Forecast to 2030 – Regional Analysis – by Type (High Myopia, Degenerative Myopia, and Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK and PRK)], Age Group (Adult Myopia and Childhood Myopia), and End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Application of Artificial Intelligence in Myopia Treatment bolsters Middle East & Africa Myopia Treatment Market
Artificial intelligence (AI) is increasingly being applied in myopia treatment. One example is using AI-powered devices to monitor and analyze eye movements and visual acuity, which can help identify early signs of myopia and track its progression. AI algorithms can also be used to develop personalized patient treatment plans based on their characteristics and medical history. In the future, AI is expected to play an even greater role in myopia treatment. For instance, researchers are exploring the use of machine learning algorithms to predict children who are at high risk of developing myopia, allowing for early intervention and prevention.
Additionally, AI-powered virtual reality systems may improve visual acuity and reduce myopia progression. Thus, the myopia treatment market is expected to see continued growth and innovation in the coming years. With the increasing prevalence of myopia worldwide, there is a growing need for effective and accessible treatments. Advancements in technology, such as AI and advanced surgical techniques, are expected to drive this growth and lead to more personalized and effective treatments for myopia. Additionally, there will likely be a greater focus on preventative measures and collaboration between industry and academia to address this global health concern.
Middle East & Africa Myopia Treatment Market Overview
Middle East & North Africa consists of three major countries: United Arab Emirates (UAE), Saudi Arabia and South Africa. UAE is the largest market for myopia treatment. The market is driven by increasing incidences of eye disorders, growing consumer awareness of myopia, and increasing penetration of international players in the region.
Saudi Arabia has made great strides in improving eye health. As per the WHO, around 8,000 children have functional low vision in Saudi Arabia. Congenital glaucoma is among the leading cause of childhood blindness in the country. Moreover, the increasing use of computers and smartphones creates demand for eye supplements during the forecast period. Prevention of blindness and deafness has been incorporated into Saudi Arabia’s new primary health care policy. To maintain a continuum of eye care, a 5-10-year program that encompasses screening for Retinopathy of Prematurity (ROP), preschool vision, diabetic retinopathy, glaucoma, and cataracts is being developed within existing health structures. The MOH is establishing four additional eye centers nationwide to deliver these services. Therefore, the government in the country is implementing campaigns and community-based education programs, which are influential elements for eye health promotion strategies. The strategies help raise awareness and encourage the community to take responsibility for eye health. The action further enforces the appropriate employment of the available eye care services. For instance, the Ministry of Health (MoH) provides educational messages on eye diseases. This helps educate people about glaucoma, myopia, amblyopia, diabetic retinopathy, and contact lenses. Thus, the abovementioned factors are expected to offer lucrative opportunities for the myopia treatment market growth in the coming years.
Middle East & Africa Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Myopia Treatment Market Segmentation
The Middle East & Africa myopia treatment market is categorized into type, treatment, age group, end user, and country.
Based on type, the Middle East & Africa myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Middle East & Africa myopia treatment market share in 2022.
In terms of treatment, the Middle East & Africa myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Middle East & Africa myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the Middle East & Africa myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Middle East & Africa myopia treatment market share in 2022.
Based on end user, the Middle East & Africa myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Middle East & Africa myopia treatment market share in 2022.
Based on country, the Middle East & Africa myopia treatment market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa myopia treatment market share in 2022.
Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, and Nidek Co Ltd are some of the leading companies operating in the Middle East & Africa myopia treatment market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Middle East & Africa myopia treatment market was valued at US$ 263.30 million in 2022 and is expected to reach US$ 465.81 million by 2030, registering a CAGR of 7.4% from 2022 to 2030. Rising prevalence of myopia and rising availability of advanced technologies for treating the targeted myopia are among the critical factors attributed to drive the Middle East & Africa myopia treatment market growth.
The rising prevalence of myopia globally represents a significant public health concern, with increasing incidences observed among children and young adults, particularly. A recent study estimated that by 2050, nearly 50% of the world’s population-or 5 billion people-will be myopic, up from the current average of 30%. it has been reported to be 42%, nearly doubling in just three decades. Multiple factors contribute to this trend, including lifestyle changes, increased urbanization, and extensive near-work activities, such as prolonged use of digital devices and limited outdoor exposure. While genetic predisposition plays a role, environmental factors also contribute to escalating the rates of myopia substantially. The impact of these lifestyle and environmental factors has led to an enhanced understanding of the complex interplay between genetic susceptibility and environmental influences, further underscoring the need for comprehensive strategies to address this burgeoning public health issue. As the prevalence of myopia continues to rise, there is a growing emphasis on developing proactive interventions, public health campaigns, and innovative treatment approaches to mitigate the long-term implications of high myopia and its associated ocular complications, thereby emphasizing the importance of addressing this multifaceted global health challenge.
On the contrary, lack of skilled professionals hurdles the growth of Middle East & Africa myopia treatment market.
Based on type, the Middle East & Africa myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held 62.6% market share in 2022, amassing US$ 164.71 million. It is projected to garner US$ 300.79 million by 2030 to register 7.8% CAGR during 2022-2030.
In terms of treatment, the Middle East & Africa myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held 38.7% share of Middle East & Africa myopia treatment market in 2022, amassing US$ 101.77 million. It is anticipated to garner US$ 185.92 million by 2030 to expand at 7.8% CAGR during 2022-2030. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the Middle East & Africa myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held 65.1% share of Middle East & Africa myopia treatment market in 2022, amassing US$ 171.33 million. It is projected to garner US$ 309.89 million by 2030 to expand at 7.7% CAGR from 2022 to 2030.
Based on end user, the Middle East & Africa myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held 65.6% share of Middle East & Africa myopia treatment market in 2022, amassing US$ 172.75 million. It is predicted to garner US$ 313.15 million by 2030 to expand at 7.7% CAGR between 2022 and 2030.
Based on country, the Middle East & Africa myopia treatment market is categorized into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 31.5% share of Middle East & Africa myopia treatment market in 2022. It was assessed at US$ 82.96 million in 2022 and is likely to hit US$ 156.23 million by 2030, registering a CAGR of 8.2% during 2022-2030.
Key players operating in the Middle East & Africa myopia treatment market are Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, and Nidek Co Ltd, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa myopia treatment market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa myopia treatment market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Myopia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies
5. Middle East & Africa Myopia Treatment Market – Key Market Dynamics
5.1 Middle East & Africa Myopia Treatment Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Myopia
5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Rising Availability of Advanced Technologies for Treating The Targeted Myopia
5.5 Future Trends
5.5.1 Application of Artificial Intelligence in Myopia Treatment
5.6 Impact of Drivers and Restraints:
6. Myopia Treatment Market – Middle East & Africa Market Analysis
7. Middle East & Africa Myopia Treatment Market Analysis – by Type
7.1 High Myopia
7.1.1 Overview
7.1.2 High Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
7.2.1 Overview
7.2.2 Degenerative Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
7.3.1 Overview
7.3.2 Progressive Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Myopia Treatment Market Analysis – by Treatment
8.1 Low-Dose Atropine Eye Drops
8.1.1 Overview
8.1.2 Low-Dose Atropine Eye Drops: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
8.2.1 Overview
8.2.2 Refractive Surgery: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2.3 LASIK
8.2.4 PRK
8.3 Contact Lenses
8.3.1 Overview
8.3.2 Contact Lenses: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
8.4.1 Overview
8.4.2 Ortho-K: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Myopia Treatment Market Analysis – by Age Group
9.1 Adult Myopia
9.1.1 Overview
9.1.2 Adult Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
9.2.1 Overview
9.2.2 Childhood Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Myopia Treatment Market Analysis – by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
10.2.1 Overview
10.2.2 Specialty Clinics: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
10.3.1 Overview
10.3.2 Refractive Surgery Centers: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Myopia Treatment Market – Country Analysis
11.1 Middle East & Africa
11.1.1 Middle East & Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.1.1.1 Middle East & Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.1.1.2 Saudi Arabia
11.1.1.3 Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Saudi Arabia: Myopia Treatment Market Breakdown, by Type
11.1.1.3.2 Saudi Arabia: Myopia Treatment Market Breakdown, by Treatment
11.1.1.3.3 Saudi Arabia: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.3.4 Saudi Arabia: Myopia Treatment Market Breakdown, by Age Group
11.1.1.3.5 Saudi Arabia: Myopia Treatment Market Breakdown, by End User
11.1.1.4 South Africa
11.1.1.5 South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 South Africa: Myopia Treatment Market Breakdown, by Type
11.1.1.5.2 South Africa: Myopia Treatment Market Breakdown, by Treatment
11.1.1.5.3 South Africa: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.5.4 South Africa: Myopia Treatment Market Breakdown, by Age Group
11.1.1.5.5 South Africa: Myopia Treatment Market Breakdown, by End User
11.1.1.6 UAE
11.1.1.7 UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.7.1 UAE: Myopia Treatment Market Breakdown, by Type
11.1.1.7.2 UAE: Myopia Treatment Market Breakdown, by Treatment
11.1.1.7.3 UAE: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.7.4 UAE: Myopia Treatment Market Breakdown, by Age Group
11.1.1.7.5 UAE: Myopia Treatment Market Breakdown, by End User
11.1.1.8 Rest of Middle East & Africa
11.1.1.9 Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.9.1 Rest of Middle East & Africa: Myopia Treatment Market Breakdown, by Type
11.1.1.9.2 Rest of Middle East & Africa: Myopia Treatment Market Breakdown, by Treatment
11.1.1.9.3 Rest of Middle East & Africa: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.9.4 Rest of Middle East & Africa: Myopia Treatment Market Breakdown, by Age Group
11.1.1.9.5 Rest of Middle East & Africa: Myopia Treatment Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CooperVision Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Nidek Co Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Carl Zeiss AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
14.2 Glossary of Terms
Table 1. Middle East & Africa Myopia Treatment Market Segmentation
Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
Table 3. Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 4. Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 5. Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 6. Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 7. Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Country
Table 8. Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 9. Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 10. Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 11. Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 12. Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 13. South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 14. South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 15. South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 16. South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 17. South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 18. UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 19. UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 20. UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 21. UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 22. UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 23. Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 24. Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 25. Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 26. Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 27. Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 28. Recent Organic Growth Strategies in Myopia Treatment Market
Table 29. Recent Inorganic Growth Strategies in the Myopia Treatment Market
Table 30. Glossary of Terms, Myopia Treatment Market
Figure 1. Middle East & Africa Myopia Treatment Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Myopia Treatment Market Revenue (US$ Million), 2020-2030
Figure 5. Middle East & Africa Myopia Treatment Market Share (%) – by Type (2022 and 2030)
Figure 6. High Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Degenerative Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Progressive Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Myopia Treatment Market Share (%) – by Treatment (2022 and 2030)
Figure 10. Low-Dose Atropine Eye Drops: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Refractive Surgery: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. LASIK: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. PRK: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Contact Lenses: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ortho-K: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Middle East & Africa Myopia Treatment Market Share (%) – by Age Group (2022 and 2030)
Figure 17. Adult Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Childhood Myopia: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Myopia Treatment Market Share (%) – by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Refractive Surgery Centers: Middle East & Africa Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Middle East & Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Growth Strategies in Myopia Treatment Market
The List of Companies – Middle East & Africa Myopia Treatment Market
1. Alcon AG
2. Bausch Health Companies Inc
3. Carl Zeiss AG
4. CooperVision Inc
5. Johnson & Johnson Vision Care Inc
6. Nidek Co Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.